BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

540204

EIKO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

EIKO LIFESCIENCES LIMITED Share Price Update

As of the latest trading session, EIKO LIFESCIENCES LIMITED share price is currently at ₹ 51.53, which is down by ₹ -0.70 from its previous closing. Today, the stock has fluctuated between ₹ 51.51 and ₹ 52.79. Over the past year, EIKO LIFESCIENCES LIMITED has achieved a return of -8.12 %. In the last month alone, the return has been -5.94 %. Read More...

Investment Returns

Over 1 Month -5.94% Over 3 Months 4.75% Over 6 Months 15.19% Over 1 Year -8.12%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

EIKO LIFESCIENCES LIMITED fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    70.70

  • P/E Ratio (TTM)

    34.36

  • Beta

    0.62

  • Book Value / share

    41.09

  • Return on equity

    2.75%

  • EPS (TTM)

    1.33

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.69

info icon alternate text

EIKO LIFESCIENCES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 7.45
Operating Expense 7.10
Net Profit 0.69
Net Profit Margin (%) 9.26
Earnings Per Share (EPS) 0.50
EBITDA 1.08
Effective Tax Rate (%) 24.17
Particulars MAR 2025 (Values in Cr)
Revenue 7.09
Operating Expense 6.77
Net Profit 0.90
Net Profit Margin (%) 12.69
Earnings Per Share (EPS) 0.69
EBITDA 1.39
Effective Tax Rate (%) 24.16
Particulars DEC 2024 (Values in Cr)
Revenue 6.91
Operating Expense 6.63
Net Profit 0.28
Net Profit Margin (%) 4.05
Earnings Per Share (EPS) 0.24
EBITDA 0.55
Effective Tax Rate (%) 26.31
Particulars SEP 2024 (Values in Cr)
Revenue 7.74
Operating Expense 7.59
Net Profit 0.21
Net Profit Margin (%) 2.71
Earnings Per Share (EPS) 0.16
EBITDA 0.48
Effective Tax Rate (%) 25.00
Particulars JUN 2024 (Values in Cr)
Revenue 10.75
Operating Expense 10.54
Net Profit 0.35
Net Profit Margin (%) 3.25
Earnings Per Share (EPS) 0.27
EBITDA 0.66
Effective Tax Rate (%) 23.91
Particulars MAR 2025 (Values in Cr)
Revenue 32.49
Operating Expense 31.54
Net Profit 1.74
Net Profit Margin (%) 5.35
Earnings Per Share (EPS) 1.34
EBITDA 3.07
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 27.93
Operating Expense 27.12
Net Profit 0.75
Net Profit Margin (%) 2.68
Earnings Per Share (EPS) 0.73
EBITDA 1.78
Effective Tax Rate (%) 23.46
Particulars MAR 2023 (Values in Cr)
Revenue 18.32
Operating Expense 18.15
Net Profit 0.77
Net Profit Margin (%) 4.20
Earnings Per Share (EPS) 0.92
EBITDA 1.81
Effective Tax Rate (%) 25.24
Particulars MAR 2022 (Values in Cr)
Revenue 25.43
Operating Expense 25.14
Net Profit 0.71
Net Profit Margin (%) 2.79
Earnings Per Share (EPS) 0.90
EBITDA 1.96
Effective Tax Rate (%) 25.53
Particulars MAR 2021 (Values in Cr)
Revenue 11.99
Operating Expense 11.62
Net Profit 0.61
Net Profit Margin (%) 5.08
Earnings Per Share (EPS) 1.61
EBITDA 0.98
Effective Tax Rate (%) 26.50
Particulars MAR 2025 (Values in Cr)
Book Value / Share 41.26
ROE % 3.61
ROCE % 4.84
Total Debt to Total Equity 0.05
EBITDA Margin 9.60
Particulars MAR 2020 (Values in Cr)
Book Value / Share 7.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.38
EBITDA Margin -43.27
Particulars MAR 2019 (Values in Cr)
Book Value / Share 12.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.30
EBITDA Margin -14.99
Particulars MAR 2018 (Values in Cr)
Book Value / Share 14.56
ROE % 3.60
ROCE % 4.66
Total Debt to Total Equity 0.31
EBITDA Margin 17.80
Particulars MAR 2025 (Values in Cr)
Book Value / Share 41.00
ROE % 2.75
ROCE % 3.84
Total Debt to Total Equity 0.02
EBITDA Margin 8.37
Particulars MAR 2024 (Values in Cr)
Book Value / Share 39.37
ROE % 1.87
ROCE % 2.82
Total Debt to Total Equity 0.00
EBITDA Margin 6.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 35.38
ROE % 2.65
ROCE % 3.79
Total Debt to Total Equity 0.08
EBITDA Margin 9.93
Particulars MAR 2022 (Values in Cr)
Book Value / Share 34.43
ROE % 3.45
ROCE % 6.01
Total Debt to Total Equity 0.16
EBITDA Margin 7.79
Particulars MAR 2021 (Values in Cr)
Book Value / Share 16.19
ROE % 6.77
ROCE % 9.15
Total Debt to Total Equity 0.12
EBITDA Margin 8.17
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 11.78
Total Assets 66.10
Total Liabilities 66.10
Total Equity 57.00
Share Outstanding 13860445
Price to Book Ratio 1.28
Return on Assets (%) 3.50
Return on Capital (%) 3.88
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 12.05
Total Liabilities 12.05
Total Equity 1.11
Share Outstanding 3820000
Price to Book Ratio 0.71
Return on Assets (%) -15.81
Return on Capital (%) -70.01
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 9.30
Total Liabilities 9.30
Total Equity 4.80
Share Outstanding 3820000
Price to Book Ratio 4.01
Return on Assets (%) -4.77
Return on Capital (%) -7.2
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 0.80
Total Assets 10.95
Total Liabilities 10.95
Total Equity 5.78
Share Outstanding 3820000
Price to Book Ratio 3.37
Return on Assets (%) 1.79
Return on Capital (%) 2.63
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 11.51
Total Assets 60.37
Total Liabilities 60.37
Total Equity 56.42
Share Outstanding 13860445
Price to Book Ratio 1.28
Return on Assets (%) 2.88
Return on Capital (%) 2.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.34
Total Assets 52.73
Total Liabilities 52.73
Total Equity 50.67
Share Outstanding 13860445
Price to Book Ratio 1.31
Return on Assets (%) 1.42
Return on Capital (%) 1.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 31.04
Total Liabilities 31.04
Total Equity 29.42
Share Outstanding 8316297
Price to Book Ratio 2.16
Return on Assets (%) 2.47
Return on Capital (%) 2.61
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 34.89
Total Liabilities 34.89
Total Equity 28.62
Share Outstanding 8316297
Price to Book Ratio 1.41
Return on Assets (%) 2.02
Return on Capital (%) 2.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.07
Total Assets 16.61
Total Liabilities 16.61
Total Equity 12.52
Share Outstanding 3820000
Price to Book Ratio 4.89
Return on Assets (%) 3.69
Return on Capital (%) 4.3
Particulars MAR 2025 (Values in Cr)
Net Income 3.06
Cash from Operations 3.23
Cash from Investing -11.44
Cash from Financing 6.95
Net change in Cash -1.56
Free Cash Flow 13.52
Particulars MAR 2020 (Values in Cr)
Net Income -4.93
Cash from Operations -0.30
Cash from Investing -0.70
Cash from Financing 0.94
Net change in Cash -0.08
Free Cash Flow -0.07
Particulars MAR 2019 (Values in Cr)
Net Income -0.99
Cash from Operations 0.18
Cash from Investing -0.29
Cash from Financing -0.55
Net change in Cash -0.68
Free Cash Flow 0.38
Particulars MAR 2025 (Values in Cr)
Net Income 2.31
Cash from Operations 2.33
Cash from Investing -9.85
Cash from Financing 5.97
Net change in Cash -1.83
Free Cash Flow 3.66
Particulars MAR 2024 (Values in Cr)
Net Income 0.98
Cash from Operations -7.04
Cash from Investing -0.54
Cash from Financing 20.36
Net change in Cash 12.73
Free Cash Flow -6.69
Particulars MAR 2023 (Values in Cr)
Net Income 1.02
Cash from Operations 4.14
Cash from Investing 0.87
Cash from Financing -4.70
Net change in Cash 0.39
Free Cash Flow 4.37
Particulars MAR 2022 (Values in Cr)
Net Income 0.94
Cash from Operations -7.51
Cash from Investing 0.59
Cash from Financing 3.28
Net change in Cash -3.85
Free Cash Flow -7.36
Particulars MAR 2021 (Values in Cr)
Net Income 0.83
Cash from Operations -0.64
Cash from Investing -2.93
Cash from Financing 7.81
Net change in Cash 4.05
Free Cash Flow -0.64
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 6329.95 37.29 3.32 18636.48 4882.00 / 8165.25
BASF INDIA LTD 4628.70 51.42 5.51 20035.62 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 330.05 46.55 1.67 1110.74 252.40 / 656.00
DEEPAK FERTILIZERS & PETR 1406.60 18.10 2.84 17756.61 888.25 / 1776.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 186.40 55.81 4.25 16.78 168.70 / 330.00
ATUL LTD 6329.95 41.90 3.36 18636.48 4882.00 / 8165.25
BASF INDIA LTD 4628.70 48.68 5.47 20035.62 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 330.05 27.14 1.63 1110.74 252.40 / 656.00

EIKO LIFESCIENCES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
51.53 -1.34 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 52.20
  • 26 Days 53.40
  • 10 Days 52.60
  • 50 Days 53.50
  • 12 Days 52.80
  • 100 Days 53.50
  • 20 Days 53.20
  • 200 Days 54.50
51.89 PIVOT

First Support

51.38

First Resistance

52.74

Second Support

50.53

Second Resistance

53.25

Third Support

50.02

Third Resistance

54.10

RSI

43.99

ADX

31.79

MACD

-0.61

Williams % R

-75.15

Commodity Channel Index (CCI)

-148.89

Date

2025-09-01

Week

6937.00

Same Day

13265.00

Month

6167.00

1 Year

0.62

3 Year

0.42

Over 1 Month

-5.94%

down

Over 1 Year

-8.12%

down

Over 3 Months

4.75%

down

Over 3 Years

16.97%

down

Over 6 Months

15.19%

down

Over 5 Years

12.49%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

EIKO LIFESCIENCES LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

EIKO LIFESCIENCES LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
20 Sep 2017 0.25 Final 22 Sep 2017 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

EIKO LIFESCIENCES LIMITED Share Price

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited. Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021. Earlier, the Company engaged in sale and purchase of shares and securities. At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally.

The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India. The key products manufactured by Company are used in pharmaceutical and agrochemical industries with various end use application including corrosion control, photographic chemicals, solvents, and corrosion inhibitors amongst others.

In 2022, it completed the development of new molecules for Agrochemical Intermediates, Polymer Science and Pharma segment. Eiko developed these molecules and launched the same during the second quarter of FY 2022.

The Company has ventured in the business of manufacturing, processing, formulating, producing, buying, selling, and exporting Speciality and Fine Chemicals in year 2023. These products find application in a host of Agrochemical, Personal Care industries,
and food industry.

Parent organization Indian Private
NSE symbol [-]
Founded 1977
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Eiko Lifesciences Ltd?

Answer Field

Eiko Lifesciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 51.53 as on Sep 02 2025 03:27 PM.

What is the Market Cap of Eiko Lifesciences Ltd Share?

Answer Field

The market cap of Eiko Lifesciences Ltd for NSE ₹ 0.00 & for BSE ₹ 70.70 as on Sep 02 2025 03:27 PM.

What is the 52 Week High and Low of Eiko Lifesciences Ltd?

Answer Field

The 52 Week High and Low of Eiko Lifesciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 74.88 and ₹ 42.00.

What is 1 year return for Eiko Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been -8.12%.

What is the P/E Ratio of Eiko Lifesciences Ltd Share?

Answer Field

As on Sep 02 2025 03:27 PM the price-to-earnings (PE) ratio for Eiko Lifesciences Ltd share is 34.36.

What is the PB ratio of Eiko Lifesciences Ltd Share?

Answer Field

As on Sep 02 2025 03:27 PM, the price-to-book (PB) ratio for Eiko Lifesciences Ltd share is 41.09.

How to Buy Eiko Lifesciences Ltd Share?

Answer Field

You can trade in Eiko Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Eiko Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Eiko Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Eiko Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91